Form 4: Beachbody Director Bennet Van de Bunt Granted 9,536 Deferred Restricted Stock Units

Beachbody Company, Inc. director Bennet Van de Bunt was granted 9,536 Deferred Restricted Stock Units (DSUs) on June 4, 2025, as part of the company's director Deferred Compensation Plan.

Summary

• Bennet Van de Bunt, a Director of The Beachbody Company, Inc. (BODI), was granted 9,536 Deferred Restricted Stock Units (DSUs).
• The transaction date for this grant was June 4, 2025.
• These DSUs were acquired at a price of $0, which is typical for equity grants.
• Following this transaction, Mr. Van de Bunt beneficially owns 9,536 DSUs directly.
• The DSUs are part of the company's director Deferred Compensation Plan.
• Payment of these DSUs can be made in cash or shares at the Issuer's discretion.
• Payment will occur within 45 days following the earliest of the director's separation from service, death, disability, or a change in control.
• The DSUs vest on the earlier of the first anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service.
• There is no expiration date for these DSUs.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally a positive signal for alignment of interests and retention, though it's a routine compensation event rather than a significant operational or financial announcement.

Positives

• The grant of 9,536 Deferred Restricted Stock Units (DSUs) to Director Bennet Van de Bunt aligns his interests with long-term shareholder value, as the vesting is tied to continued service.
• The DSUs are part of a deferred compensation plan, which can be a positive for director retention and long-term commitment.

Risks

• The ultimate value of the DSUs to the director is tied to the future stock price of The Beachbody Company, Inc., meaning their value could fluctuate.
• Vesting of the DSUs is subject to continued service with the company, meaning the director must remain with the company to realize the full benefit.

Future Outlook

The vesting schedule for the Deferred Restricted Stock Units (DSUs) indicates a future commitment from Director Bennet Van de Bunt, with vesting occurring on the earlier of the first anniversary of the grant date (June 4, 2026) or the date of the next annual meeting following the grant date, subject to continued service.

Industry Context

This Form 4 filing reflects a routine equity compensation event for a director, common across publicly traded companies to align executive and director interests with shareholder value. Such grants are standard practice in the wellness and fitness industry, where companies like Beachbody often use equity to incentivize long-term performance and retention of key personnel.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as part of a deferred compensation plan for directors is a common practice in corporate governance across various industries, including the health and wellness sector.
• Companies such as Peloton Interactive, Inc. (PTON) or Lululemon Athletica Inc. (LULU) also utilize equity-based compensation to incentivize their leadership.
• The specific number of units granted (9,536 DSUs) would need to be assessed against the director's overall compensation package and the company's market capitalization to determine its relative significance compared to similar grants at peer companies.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of DSUs aligns the director's interests with shareholders by tying compensation to the company's stock performance and long-term value creation.

Next Steps

• The DSUs will vest on the earlier of June 4, 2026 (first anniversary of grant date) or the date of the next annual meeting following the grant date, subject to continued service.
• Payment of DSUs will occur within 45 days following the earliest of the director's separation from service, death, disability, or a change in control.

Key Dates

Keywords

Beachbody Company Inc., BODI, SEC Form 4, Restricted Stock Units, RSU, Deferred Compensation, Director Compensation, Equity Grant, Insider Transaction